475 related articles for article (PubMed ID: 19434849)
21. Metastability and transformation of polymorphic crystals in biodegradable poly(butylene adipate).
Gan Z; Kuwabara K; Abe H; Iwata T; Doi Y
Biomacromolecules; 2004; 5(2):371-8. PubMed ID: 15002996
[TBL] [Abstract][Full Text] [Related]
22. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
23. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
Shete G; Khomane KS; Bansal AK
J Pharm Sci; 2014 Jan; 103(1):167-78. PubMed ID: 24186540
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin.
Trasi NS; Boerrigter SX; Byrn SR
Pharm Res; 2010 Jul; 27(7):1377-89. PubMed ID: 20490628
[TBL] [Abstract][Full Text] [Related]
25. Physical stability of the amorphous anticholesterol agent (ezetimibe): the role of molecular mobility.
Knapik J; Wojnarowska Z; Grzybowska K; Hawelek L; Sawicki W; Wlodarski K; Markowski J; Paluch M
Mol Pharm; 2014 Nov; 11(11):4280-90. PubMed ID: 25310722
[TBL] [Abstract][Full Text] [Related]
26. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
[TBL] [Abstract][Full Text] [Related]
27. The thermotropic phase behaviour and phase structure of a homologous series of racemic beta-D-galactosyl dialkylglycerols studied by differential scanning calorimetry and X-ray diffraction.
Mannock DA; Collins MD; Kreichbaum M; Harper PE; Gruner SM; McElhaney RN
Chem Phys Lipids; 2007 Jul; 148(1):26-50. PubMed ID: 17524381
[TBL] [Abstract][Full Text] [Related]
28. Molecular dynamics of ethylene glycol dimethacrylate glass former: influence of different crystallization pathways.
Viciosa MT; Correia NT; Salmerón Sánchez M; Gómez Ribelles JL; Dionísio M
J Phys Chem B; 2009 Oct; 113(43):14196-208. PubMed ID: 19845405
[TBL] [Abstract][Full Text] [Related]
29. Slow molecular mobility in the crystalline and amorphous solid states of pentitols: a study by thermally stimulated depolarisation currents and by differential scanning calorimetry.
Diogo HP; Pinto SS; Moura Ramos JJ
Carbohydr Res; 2007 May; 342(7):961-9. PubMed ID: 17303096
[TBL] [Abstract][Full Text] [Related]
30. Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability.
Alhalaweh A; Alzghoul A; Mahlin D; Bergström CAS
Int J Pharm; 2015 Nov; 495(1):312-317. PubMed ID: 26341321
[TBL] [Abstract][Full Text] [Related]
31. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
[TBL] [Abstract][Full Text] [Related]
32. Correlating thermodynamic and kinetic parameters with amorphous stability.
Graeser KA; Patterson JE; Zeitler JA; Gordon KC; Rades T
Eur J Pharm Sci; 2009 Jun; 37(3-4):492-8. PubMed ID: 19394421
[TBL] [Abstract][Full Text] [Related]
33. Effects of heating conditions on the glass transition parameters of amorphous sucrose produced by melt-quenching.
Lee JW; Thomas LC; Schmidt SJ
J Agric Food Chem; 2011 Apr; 59(7):3311-9. PubMed ID: 21381719
[TBL] [Abstract][Full Text] [Related]
34. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility.
Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
J Pharm Sci; 2002 Aug; 91(8):1863-72. PubMed ID: 12115813
[TBL] [Abstract][Full Text] [Related]
35. Effect of counterions on the properties of amorphous atorvastatin salts.
Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK
Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794
[TBL] [Abstract][Full Text] [Related]
36. Trehalose amorphization and recrystallization.
Sussich F; Cesàro A
Carbohydr Res; 2008 Oct; 343(15):2667-74. PubMed ID: 18768170
[TBL] [Abstract][Full Text] [Related]
37. Isothermal Crystallization Monitoring and Time-Temperature-Transformation of Amorphous GDC-0276: Differential Scanning Calorimetric and Rheological Measurements.
Cheng S; Chakravarty P; Nagapudi K; McKenna GB
Mol Pharm; 2021 Jan; 18(1):158-173. PubMed ID: 33259220
[TBL] [Abstract][Full Text] [Related]
38. Surface-enhanced crystallization of amorphous nifedipine.
Zhu L; Wong L; Yu L
Mol Pharm; 2008; 5(6):921-6. PubMed ID: 19434917
[TBL] [Abstract][Full Text] [Related]
39. Microscopic molecular mobility of amorphous AG-041R measured by solid-state 13C NMR.
Koga A; Yonemochi E; Machida M; Aso Y; Ushio H; Terada K
Int J Pharm; 2004 May; 275(1-2):73-83. PubMed ID: 15081139
[TBL] [Abstract][Full Text] [Related]
40. Structural signature of slow dynamics and dynamic heterogeneity in two-dimensional colloidal liquids: glassy structural order.
Kawasaki T; Tanaka H
J Phys Condens Matter; 2011 May; 23(19):194121. PubMed ID: 21525551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
